Germania: 81322845-MAV+: Technical assistance for selected companies in the pharmaceutical sector in South Africa for the SAVax project
Data licitatiei 05.05.2026
Expirat

18

18
| Valoare estimata : 0
|
Tip anunt:
UE
|
ID: 10769892
|
Data publicarii :
07.04.2026
|
Tara/Judet:
GE |
|
Descriere scurta:
Germania: 81322845-MAV+: Technical assistance for selected companies in the pharmaceutical sector in South Africa for the SAVax project
Coduri CPV:
73200000-4 - Servicii de consultanţă în cercetare şi în dezvoltare
79411100-9 - Servicii de consultanţă în dezvoltarea societăţilor
|
Textul licitației
frica" (SAVax) is part of South Africa's strategic objective to enhance the local production of vaccines, medicines, and health technologies. Co-financed by the German Federal Ministry for Economic Cooperation and Development (BMZ) and the European Union (EU), SAVax aims to strengthen local manufacturing capacity in the biopharmaceutical industry and improve access to essential health products. The initiative aligns with the goals of key South African government partners, including the Department of Science, Technology and Innovation (DSTI), the Department of Health (DoH), and the South African Health Products Regulatory Authority (SAHPRA), to create a sustainable and competitive biopharmaceutical sector. The project aims at supporting selected South African biopharmaceutical companies with "ready-for-market" products, providing targeted technical assistance to improve their manufacturin